EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Novel topical and systemic therapies in atopic dermatitis


Novel topical and systemic therapies in atopic dermatitis



Immunological Medicine 42(2): 84-93



ISSN/ISBN: 2578-5826

PMID: 31318324

DOI: 10.1080/25785826.2019.1642727

Atopic dermatitis (AD) is the most common inflammatory skin disease driven by both terminal keratinocyte differentiation defects and type 2 immune responses, and this condition causes psychological and social morbidity. Although patients with severe AD require systemic immunotherapy, conventional agents including ciclosporin could not be used for several years due to side effects such as nephrotoxicity, hypertension and long-term risks of malignancy. It is well known that dupilumab, which blocks receptor binding of both IL-4 and IL-13, is remarkably efficacious in the treatment of AD. We have entered a new era when many novel topical and systemic agents that may have great potential in AD treatment are emerging through clinical trials. The purpose of this article is to summarize the efficacy and safety of the current topical and systemic therapies in AD by reviewing recently published papers regarding phase II/III clinical trials. It is revealed that topical phosphodiesterase 4 inhibitors and Janus kinase (JAK) inhibitors are promising treatments for AD. Moreover, systemic therapies such as biologics targeting IL-13 and oral JAK inhibitors show strong efficacy in AD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 069159716

Download citation: RISBibTeXText

Related references

Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents. Journal of Dermatological Treatment 2020: 1-5, 2020

Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis. Dermatology and Therapy 12(5): 1181-1196, 2022

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. Journal of the American Academy of Dermatology 71(1): 116-132, 2014

Review of Atopic Dermatitis and Topical Therapies. Journal of cutaneous medicine and surgery 21(3): 227-236, 2017

New Topical Therapies in Development for Atopic Dermatitis. Drugs 82(8): 843-853, 2022

New and Emerging Topical Therapies for Psoriasis and Atopic Dermatitis. Journal of Clinical and Aesthetic Dermatology 12(12): 28-34, 2019

Current and emerging topical therapies for atopic dermatitis. Clinics in Dermatology 35(4): 375-382, 2017

Atopic dermatitis: skin care and topical therapies. Seminars in Cutaneous Medicine and Surgery 36(3): 104-110, 2017

Addressing treatment challenges in atopic dermatitis with novel topical therapies. Journal of Dermatological Treatment 27(6): 568-576, 2016

A systematic review of the safety of topical therapies for atopic dermatitis. British Journal of Dermatology (1951) 156(2): 203-221, 2007

A systematic review of the safety of topical therapies for atopic dermatitis. British Journal of Dermatology 156(2): 203-221, 2007

Emerging Treatment Options in Atopic Dermatitis: Topical Therapies. Dermatology 233(5): 333-343, 2017

Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clinical and Experimental Dermatology 28(5): 549-553, 2003

A review of patient adherence to topical therapies for treatment of atopic dermatitis. Cutis 96(6): 397-401, 2015

Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis. Children 6(11), 2019